These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 28066708)
1. Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers. Kayser AS; Vega T; Weinstein D; Peters J; Mitchell JM Neuroimage Clin; 2017; 13():339-348. PubMed ID: 28066708 [TBL] [Abstract][Full Text] [Related]
2. Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers. Magalona SC; Rasetti R; Chen J; Chen Q; Gold I; Decot H; Callicott JH; Berman KF; Apud JA; Weinberger DR; Mattay VS CNS Drugs; 2013 Aug; 27(8):663-73. PubMed ID: 23794107 [TBL] [Abstract][Full Text] [Related]
3. Dopamine, locus of control, and the exploration-exploitation tradeoff. Kayser AS; Mitchell JM; Weinstein D; Frank MJ Neuropsychopharmacology; 2015 Jan; 40(2):454-62. PubMed ID: 25074639 [TBL] [Abstract][Full Text] [Related]
4. Dopamine, time perception, and future time perspective. Mitchell JM; Weinstein D; Vega T; Kayser AS Psychopharmacology (Berl); 2018 Oct; 235(10):2783-2793. PubMed ID: 30027496 [TBL] [Abstract][Full Text] [Related]
5. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739 [TBL] [Abstract][Full Text] [Related]
6. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Ashare RL; Wileyto EP; Ruparel K; Goelz PM; Hopson RD; Valdez JN; Gur RC; Loughead J; Lerman C Drug Alcohol Depend; 2013 Dec; 133(3):852-6. PubMed ID: 24095246 [TBL] [Abstract][Full Text] [Related]
7. Tolcapone improves cognition and cortical information processing in normal human subjects. Apud JA; Mattay V; Chen J; Kolachana BS; Callicott JH; Rasetti R; Alce G; Iudicello JE; Akbar N; Egan MF; Goldberg TE; Weinberger DR Neuropsychopharmacology; 2007 May; 32(5):1011-20. PubMed ID: 17063156 [TBL] [Abstract][Full Text] [Related]
8. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice. Detrait ER; Carr GV; Weinberger DR; Lamberty Y Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286 [TBL] [Abstract][Full Text] [Related]
9. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Giakoumaki SG; Roussos P; Bitsios P Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698 [TBL] [Abstract][Full Text] [Related]
10. A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Grant JE; Odlaug BL; Chamberlain SR; Hampshire A; Schreiber LR; Kim SW Eur Neuropsychopharmacol; 2013 Nov; 23(11):1587-96. PubMed ID: 23953269 [TBL] [Abstract][Full Text] [Related]
11. Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex. Lapish CC; Ahn S; Evangelista LM; So K; Seamans JK; Phillips AG Psychopharmacology (Berl); 2009 Jan; 202(1-3):521-30. PubMed ID: 18854987 [TBL] [Abstract][Full Text] [Related]
12. Effects of tolcapone and bromocriptine on cognitive stability and flexibility. Cameron IGM; Wallace DL; Al-Zughoul A; Kayser AS; D'Esposito M Psychopharmacology (Berl); 2018 Apr; 235(4):1295-1305. PubMed ID: 29427081 [TBL] [Abstract][Full Text] [Related]
13. Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors. Bhakta SG; Light GA; Talledo JA; Balvaneda B; Hughes E; Alvarez A; Rana BK; Young JW; Swerdlow NR Int J Neuropsychopharmacol; 2017 Dec; 20(12):979-987. PubMed ID: 29020372 [TBL] [Abstract][Full Text] [Related]
14. Sexually dimorphic effects of catechol-O-methyltransferase (COMT) inhibition on dopamine metabolism in multiple brain regions. Laatikainen LM; Sharp T; Harrison PJ; Tunbridge EM PLoS One; 2013; 8(4):e61839. PubMed ID: 23613951 [TBL] [Abstract][Full Text] [Related]
15. Enhancing dopamine tone modulates global and local cortical perfusion as a function of COMT val158met genotype. Furman DJ; Pappas I; White RL; Kayser AS; D'Esposito M Neuroimage; 2021 Nov; 242():118472. PubMed ID: 34390874 [TBL] [Abstract][Full Text] [Related]
16. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Schacht JP; Yeongbin Im ; Hoffman M; Voronin KE; Book SW; Anton RF Neuropsychopharmacology; 2022 Oct; 47(11):1953-1960. PubMed ID: 35523943 [TBL] [Abstract][Full Text] [Related]
17. Differential COMT expression and behavioral effects of COMT inhibition in male and female Wistar and alcohol preferring rats. McCane AM; DeLory MJ; Timm MM; Janetsian-Fritz SS; Lapish CC; Czachowski CL Alcohol; 2018 Mar; 67():15-22. PubMed ID: 29310047 [TBL] [Abstract][Full Text] [Related]
18. Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition. Laatikainen LM; Sharp T; Bannerman DM; Harrison PJ; Tunbridge EM J Psychopharmacol; 2012 Dec; 26(12):1561-8. PubMed ID: 22815336 [TBL] [Abstract][Full Text] [Related]
19. Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. Tunbridge EM; Bannerman DM; Sharp T; Harrison PJ J Neurosci; 2004 Jun; 24(23):5331-5. PubMed ID: 15190105 [TBL] [Abstract][Full Text] [Related]
20. Augmenting Frontal Dopamine Tone Enhances Maintenance over Gating Processes in Working Memory. Furman DJ; Zhang Z; Chatham CH; Good M; Badre D; Hsu M; Kayser AS J Cogn Neurosci; 2021 Aug; 33(9):1753-1765. PubMed ID: 33054556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]